Upgrades:
Phillips 66 (NYSE:PSX) was upgraded by investment analysts at The Goldman Sachs Group from a “buy” rating to a “conviction-buy” rating in a research note issued on Wednesday, The Fly reports.
Several other equities research analysts also recently
issued reports on PSX. Piper Sandler upgraded Phillips 66 from a “neutral”
rating to an “overweight” rating and lifted their price objective for the stock
from $85.00 to $87.00 in a report on Wednesday, October 6th. Citigroup boosted
their price target on Phillips 66 from $75.00 to $80.00 and gave the company a
“neutral” rating in a report on Wednesday, October 6th. Royal Bank of Canada
boosted their price target on Phillips 66 from $94.00 to $95.00 and gave the
company an “outperform” rating in a report on Tuesday. Barclays lowered their
price target on Phillips 66 from $95.00 to $88.00 and set an “overweight”
rating for the company in a report on Thursday, July 8th. Finally, Morgan
Stanley boosted their price target on Phillips 66 from $90.00 to $95.00 and
gave the company an “equal weight” rating in a report on Monday. Five
investment analysts have rated the stock with a hold rating, twelve have given
a buy rating and one has given a strong buy rating to the stock. Based on data
from MarketBeat, Phillips 66 currently has an average rating of “Buy” and an
average target price of $85.63. Read
more …
Thomson Reuters (NYSE:TRI) (TSE:TRI) was upgraded by investment analysts at BNP Paribas from an “underperform” rating to a “neutral” rating in a note issued to investors on Wednesday, Price Targets.com reports.
Several other brokerages also recently weighed in on TRI. TD
Securities upgraded Thomson Reuters from a “hold” rating to a “buy” rating and
set a $160.00 price target for the company in a report on Wednesday, October
6th. Zacks Investment Research upgraded Thomson Reuters from a “hold” rating to
a “buy” rating and set a $123.00 price target for the company in a report on
Thursday, October 7th. Royal Bank of Canada downgraded Thomson Reuters from an
“outperform” rating to a “sector perform” rating and boosted their price target
for the company from $118.00 to $122.00 in a report on Monday. Morgan Stanley
boosted their price objective on shares of Thomson Reuters from $105.00 to
$106.00 and gave the company an “equal weight” rating in a research note on
Thursday, September 23rd. Finally, National Bank Financial boosted their price
objective on shares of Thomson Reuters from C$145.00 to C$162.00 and gave the
company a “sector perform” rating in a research note on Thursday, September
2nd. Seven investment analysts have rated the stock with a hold rating and four
have given a buy rating to the company. According to MarketBeat, the company
currently has a consensus rating of “Hold” and an average target price of
$125.90. Read
more …
QUALCOMM (NASDAQ:QCOM) was upgraded by research analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports.
A number of other research analysts also recently issued
reports on the company. Canaccord Genuity reissued a “buy” rating and issued a
$225.00 price objective (up from $200.00) on shares of QUALCOMM in a research
note on Thursday, August 12th. Cowen boosted their target price on QUALCOMM
from $180.00 to $185.00 and gave the company an “outperform” rating in a
research report on Thursday, July 29th. Susquehanna reaffirmed a “hold” rating
and issued a $157.00 target price on shares of QUALCOMM in a research report on
Thursday, July 29th. Zacks Investment Research lowered QUALCOMM from a “buy”
rating to a “hold” rating and set a $135.00 target price for the company. in a
research report on Monday, October 4th. Finally, Mizuho decreased their target
price on QUALCOMM from $180.00 to $165.00 and set a “buy” rating for the
company in a research report on Tuesday, October 19th. Thirteen equities
research analysts have rated the stock with a hold rating, sixteen have
assigned a buy rating and one has assigned a strong buy rating to the company.
According to data from MarketBeat.com, the stock currently has an average
rating of “Buy” and an average price target of $166.77. Read
more…
GlaxoSmithKline (NYSE:GSK) was upgraded by stock analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued on Friday, The Fly reports.
GSK has been the topic of several other research reports.
Morgan Stanley reaffirmed an "equal weight" rating on shares of
GlaxoSmithKline in a report on Wednesday. JPMorgan Chase & Co. reaffirmed a
"neutral" rating on shares of GlaxoSmithKline in a report on Monday.
Berenberg Bank reaffirmed a "buy" rating on shares of GlaxoSmithKline
in a report on Monday, October 18th. Zacks Investment Research downgraded
shares of GlaxoSmithKline from a "hold" rating to a "sell"
rating and set a $41.00 target price on the stock. in a report on Tuesday, July
20th. Finally, UBS Group reaffirmed a "neutral" rating on shares of
GlaxoSmithKline in a report on Monday, September 20th. Two equities research
analysts have rated the stock with a sell rating, six have issued a hold rating
and three have given a buy rating to the company. Based on data from
MarketBeat.com, the stock currently has a consensus rating of "Hold"
and a consensus price target of $41.00.
GlaxoSmithKline stock opened at $43.00 on Friday. The
company has a debt-to-equity ratio of -0.95, a current ratio of 0.81 and a
quick ratio of 0.54. The business has a 50 day simple moving average of $39.81
and a 200-day simple moving average of $39.66. GlaxoSmithKline has a 12 month
low of $33.53 and a 12 month high of $43.61. The stock has a market
capitalization of $115.78 billion, a PE ratio of 18.22, a
price-to-earnings-growth ratio of 2.57 and a beta of 0.72. Read
more …
